Evidence map›Paper›PMID 38737312›Full record

ArticleJournal of the Intensive Care Society2024

Evaluating the clinical and cost-effectiveness of a conservative approach to oxygen therapy for invasively ventilated adults in intensive care: Protocol for the UK-ROX trial.

Daniel S Martin, Tasnin Shahid, Doug W Gould, Alvin Richards-Belle, James C Doidge, Julie Camsooksai, Walton N Charles, Miriam Davey, Amelia Francis Johnson, Roger M Garrett and 12 more

Abstract read
In one paragraph

Article in Journal of the Intensive Care Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Daniel S MartinPeninsula Medical School, University of Plymouth, Plymouth, UK.ORCID https://orcid.org/0000-0001-6220-8235
Tasnin ShahidClinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), Napier House, London, UK.
Doug W GouldClinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), Napier House, London, UK.ORCID https://orcid.org/0000-0003-4148-3312
Alvin Richards-BelleClinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), Napier House, London, UK.ORCID https://orcid.org/0000-0001-8577-9380
James C DoidgeClinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), Napier House, London, UK.
Julie CamsooksaiClinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), Napier House, London, UK.
Walton N CharlesClinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), Napier House, London, UK.
Miriam DaveyCritical Care, Maidstone and Tunbridge Wells NHS Foundation Trust, Kent, UK.
Amelia Francis JohnsonClinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), Napier House, London, UK.
Roger M GarrettPatient and Public Representative, Bristol, UK.ORCID https://orcid.org/0000-0003-3593-5896
Michael Pw GrocottPerioperative and Critical Care Theme, NIHR Southampton Biomedical Research Centre, University Hospital Southampton/University of Southampton, Southampton, UK.
Joanne JonesCritical Care, Maidstone and Tunbridge Wells NHS Foundation Trust, Kent, UK.
Lamprini LamproClinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), Napier House, London, UK.
Lorna MillerClinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), Napier House, London, UK.
B Ronan O'DriscollRespiratory Medicine, Northern Care Alliance NHS Foundation Trust, Salford Royal University Hospital, Salford, UK.
Anthony J RostronIntegrated Critical Care Unit, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
Zia SadiqueDepartment of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Tamas SzakmanyCritical Care, Aneurin Bevan University Health Board, Cwmbran, UK.
Paul J YoungIntensive Care Unit, Wellington Hospital, Wellington, New Zealand.
Kathryn M RowanIntensive Care Unit, University Hospitals Plymouth NHS Trust, Plymouth, UK.
David A HarrisonIntensive Care Unit, University Hospitals Plymouth NHS Trust, Plymouth, UK.ORCID https://orcid.org/0000-0002-9002-9098
Paul R MounceyIntensive Care Unit, University Hospitals Plymouth NHS Trust, Plymouth, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In the United Kingdom, around 184,000 adults are admitted to an intensive care unit (ICU) each year with over 30% receiving mechanical ventilation. Oxygen is the commonest therapeutic intervention provided to these patients but it is unclear how much oxygen should be administered for the best clinical outcomes. Methods: The UK-ROX trial will evaluate the clinical and cost-effectiveness of conservative oxygen therapy (the minimum oxygen concentration required to maintain an oxygen saturation of 90% ± 2%) versus usual oxygen therapy in critically ill adults receiving supplemental oxygen when invasively mechanically ventilated in ICUs in England, Wales and Northern Ireland. The trial will recruit 16,500 patients from approximately 100 UK adult ICUs. Using a deferred consent model, enrolled participants will be randomly allocated (1:1) to conservative or usual oxygen therapy until ICU discharge or 90 days after randomisation. Objectives: The primary clinical outcome is all cause mortality at 90 days following randomisation. Discussion: The UK-ROX trial has received ethical approval from the South Central - Oxford C Research Ethics Committee (Reference: 20/SC/0423) and the Confidentiality Advisory Group (Reference: 22/CAG/0154). The trial commenced in May 2021 and, at the time of publication, 95 sites had opened to recruitment.

Indexed as

critical carehypoxaemiaintensive caremechanical ventilationOxygen

Identifiers

PMID38737312
PMCPMC11086723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.